UPPSALA, Sweden, Oct. 7, 2025 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision medicine company, today announced that it has conducted a first scientific advisory meeting with the Swedish Medical Products Agency regarding the drug candidate BEA-17. Specifically, the...
Hence then, the article about beactica conducts first advisory meeting with the swedish medical products agency regarding the development of bea 17 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Beactica conducts first advisory meeting with the Swedish Medical Products Agency regarding the development of BEA-17 )
Also on site :
- We Asked 4 Psychologists the Best Phrase To Use With Adult Children To Transform Your Relationship—They All Said the Same Thing
- Trump celebrates 80th birthday with a UFC fight at the White House as Americans pay the price for his Iran war
- Republican attorneys general urge EPA to classify mifepristone as water contaminant